Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia

Yasuo Kubota, Misam Zawit, Jibran Durrani, Wenyi Shen, Waled Bahaj, Tariq Kewan, Ben Ponvilawan, Minako Mori, Manja Meggendorfer, Carmelo Gurnari, Thomas LaFramboise, Simone Feurstein, Mikkael A. Sekeres, Valeria Visconte, Lucy A. Godley, Torsten Haferlach, Jaroslaw P. Maciejewski*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Broader genetic screening has led to the growing recognition of the role of germline variants associated with adult bone marrow failure (BMF) and myeloid neoplasia (MN) not exclusively in children and young adults. In this study, we applied a germline variant panel to 3008 adult BMF and MN cases to assess the importance of germline genetics and its impact on disease phenotype and prognosis. In our cohort, up to 9.7% of BMF and 5.3% of MN cases carried germline variants. Our cohort also included heterozygous carriers of recessive traits, suggesting they contribute to the risk of BMF and MN. By gene category, variants of Fanconi anemia gene family represented the highest-frequency category for both BMF and MN cases, found in 4.9% and 1.7% cases, respectively. In addition, about 1.4% of BMF and 0.19% of MN cases harbored multiple germline variants affecting often functionally related genes as compound heterozygous. The burden of germline variants in BMF and MN was clearly associated with acquisition of monosomy 7. While BMF cases carrying germline variants showed similar overall survival as compared to the wild-type (WT) cases, MN cases with germline variants experienced a significantly shorter overall survival as compared to WT cases.

Original languageEnglish (US)
Pages (from-to)2827-2834
Number of pages8
JournalLeukemia
Volume36
Issue number12
DOIs
StatePublished - Dec 2022

Funding

We thank The Torsten Haferlach Leuk\u00E4miediagnostik Stiftung to support this work. The authors also thank The Cancer Genome Atlas, The Beat AML Master Trial, and The German-Austrian Study Group for data accessibility. This work was supported by an R35HL135795 (to JPM) and The Leukemia & Lymphoma Society TRP Award 6645-22 (to JPM). SF receives funding from the Olympia Morata Program of the Medical Faculty Heidelberg.

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia'. Together they form a unique fingerprint.

Cite this